Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk Polycythemia Vera (PV)...
Abdulraheem Yacoub, M.D. presents from ASH 2017 on the final results of a large investigator-initiated trial of pegylated-rIFN-alfa-2a as salvage therapy for high-risk PV/ET patients with hydroxyurea-resistant or intolerance (MPD-RC 111).
Recent Video
Most Popular
Specialties :                    Search : is a member of the Oncology.TV family of oncology medical education websites. offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).